Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: J Neuroimmune Pharmacol. 2020 Jul 6;16(2):437–453. doi: 10.1007/s11481-020-09936-5

Figure 2. BM5Defexpression in the spleen and CNS of gp120tg mice.

Figure 2.

Young (8-10 week old) and old (4-5 months old) gp120tg+ and gp120tg− mice were euthanized at 12 weeks post-LP-BM5 treatment (5×104 pfu, i.p.). BM5 Def viral loads for spleen (A),hippocampus (B), frontal lobe (C), and striatum (D) are shown here. Data are presented as mean ± SEM; n=7-16/group. One-way ANOVA on rank followed by Dunn’s post hoc test were performed with groups that were treated with LP-BM5. $ p<0.05 between the indicated groups. ND = not detectable.